Format

Send to

Choose Destination
Oncogene. 2012 Jan 26;31(4):480-93. doi: 10.1038/onc.2011.249. Epub 2011 Jun 27.

MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis.

Author information

1
Laboratory of Tumor and Developmental Biology, GIGA-Cancer, Institute of Pathology, University of Liège, Liège, Belgium. erik.maquoi@ulg.ac.be

Abstract

As invading breast carcinoma cells breach their underlying basement membrane, they become confronted with a dense three-dimensional reactive stroma dominated by type I collagen. To develop metastatic capabilities, invading tumor cells must acquire the capacity to negotiate this novel microenvironment. Collagen influences the fate of epithelial cells by inducing apoptosis. However, the mechanisms used by invading tumor cells to evade collagen-induced apoptosis remain to be defined. We demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14) confers breast cancer cells with the ability to escape apoptosis when embedded in a collagen gel and after orthotopic implantation in vivo. In the absence of MMP-14-dependent proteolysis, type I collagen triggers apoptosis by inducing the expression of the pro-apoptotic Bcl-2-interacting killer in luminal-like breast cancer cells. These findings reveal a new mechanism whereby MMP-14 activity promotes tumor progression by circumventing apoptosis.

PMID:
21706048
DOI:
10.1038/onc.2011.249
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center